News Posted on February 4, 2026 Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger – Law360 Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger Law360 Source: Stem-Cell Drug Developer PrimeGen Inks .5B SPAC Merger – Law360 By sf-admin